bromodeoxyuridine has been researched along with Autoimmune Experimental Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campagnolo, DI; Dayao, CS; Hao, J; Liu, R; Shi, FD | 1 |
1 other study(ies) available for bromodeoxyuridine and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
T-bet deficiency decreases susceptibility to experimental myasthenia gravis.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; CD4 Antigens; Cell Proliferation; Cell Separation; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunoglobulin G; Interleukin-2 Receptor alpha Subunit; Mice; Mice, Inbred C57BL; Mice, Knockout; Myasthenia Gravis, Autoimmune, Experimental; Receptors, Cholinergic; T-Box Domain Proteins; T-Lymphocytes, Helper-Inducer; Th1 Cells; Th2 Cells | 2009 |